Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease

Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease

PurposeVitamin D is associated with various pathological conditions such as cardiovascular diseases and cancer. We investigated the relationship between vitamin D and Kawasaki disease (KD).MethodsWe performed a retrospective review of the medical records of patients with KD between February 2013 and...

Full description

Bibliographic Details
Main Authors:	Jae Sung Jun, Young Kwon Jung, Dong Won Lee
Format:	Article
Language:	English
Published:	Korean Pediatric Society 2017-07-01
Series:	Korean Journal of Pediatrics
Subjects:	Vitamin D Kawasaki disease Inflammation
Online Access:	http://kjp.or.kr/upload/pdf/kjped-60-216.pdf

Similar Items

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013-01-01)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013-01-01)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
by: Min Seob Song
Published: (2019-04-01)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
by: Yaheng Lu, et al.
Published: (2021-09-01)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013-02-01)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01)

Does Vitamin C improve endothelial function in patients with Kawasaki disease?
by: Mohammad Reza Sabri, et al.
Published: (2015-01-01)

Predictors of Intravenous Immunoglobulin (IVIG) Resistance in Children with Kawasaki Disease in Calabria Region, Italy
by: Valentina Talarico, et al.
Published: (2019-02-01)

Use of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
by: Abdolkarim Hamedi, et al.
Published: (2017-08-01)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
by: Hye Young Lee, et al.
Published: (2016-12-01)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
by: Euri Seo, et al.
Published: (2016-10-01)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
by: Weiguo Qian, et al.
Published: (2018-03-01)

Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease
by: Matsuura Hiroyuki, et al.
Published: (2011-09-01)

The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
by: Jae Won Yoo, et al.
Published: (2017-01-01)

Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
by: Xiaoliang Liu, et al.
Published: (2021-08-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease
by: Ming-Tai Lin, et al.
Published: (2016-05-01)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014-10-01)

Diagnostic characteristics of supplemental laboratory criteria for incomplete Kawasaki disease in children with complete Kawasaki disease
by: Hyun Ok Jun, et al.
Published: (2015-10-01)

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
by: Ying-Hua Huang, et al.
Published: (2021-08-01)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
by: Yongbing Chen, et al.
Published: (2019-03-01)

Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population
by: Li Meng, et al.
Published: (2021-06-01)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
by: Khanh-Van Y. Van Anh, et al.
Published: (2020-04-01)

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
by: Donato Rigante, et al.
Published: (2016-02-01)

Integrating Co-Clustering and Interpretable Machine Learning for the Prediction of Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Haolin Wang, et al.
Published: (2020-01-01)

Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies
by: Gengying Liu, et al.
Published: (2020-04-01)

Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease
by: Miyakoshi, Chisato
Published: (2019)

Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study
by: Yu Yan, et al.
Published: (2021-09-01)

Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study
by: Zhenquan Wang, et al.
Published: (2018-02-01)

A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review
by: Na Yeon Kim, et al.
Published: (2016-11-01)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
by: Ho-Chang Kuo, et al.
Published: (2018-06-01)

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages
by: Tatyana V. Sleptsova, et al.
Published: (2016-09-01)

Refractory Kawasaki disease: diagnostic and management challenges
by: Duignan S, et al.
Published: (2019-10-01)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Chih-Min Tsai, et al.
Published: (2020-11-01)

Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease
by: Shashaani N, et al.
Published: (2020-08-01)

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
by: Saori Fukui, et al.
Published: (2021-07-01)

Prediction for Intravenous Immunoglobulin Resistance Combining Genetic Risk Loci Identified From Next Generation Sequencing and Laboratory Data in Kawasaki Disease
by: Liqin Chen, et al.
Published: (2020-12-01)

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
by: Shu Wu, et al.
Published: (2019-12-01)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
by: Fan Yan, et al.
Published: (2020-11-01)

Enfermedad de Kawasaki:: reporte de 3 casos Kawasaki's disease:: report on 3 cases
by: Gladys Fernández Couce, et al.
Published: (2010-06-01)